428 related articles for article (PubMed ID: 21689785)
1. Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Chong Y; Ito Y; Kamimura T
Infect Genet Evol; 2011 Oct; 11(7):1499-504. PubMed ID: 21689785
[TBL] [Abstract][Full Text] [Related]
2. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
Onnberg A; Mölling P; Zimmermann J; Söderquist B
APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
Zhang WL; Liu J; Zhang J; Su GL
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232
[TBL] [Abstract][Full Text] [Related]
5. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
[TBL] [Abstract][Full Text] [Related]
7. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
10. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
[TBL] [Abstract][Full Text] [Related]
13. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia.
Tawfik AF; Alswailem AM; Shibl AM; Al-Agamy MH
Microb Drug Resist; 2011 Sep; 17(3):383-8. PubMed ID: 21612509
[TBL] [Abstract][Full Text] [Related]
16. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Lautenbach E; Patel JB; Bilker WB; Edelstein PH; Fishman NO
Clin Infect Dis; 2001 Apr; 32(8):1162-71. PubMed ID: 11283805
[TBL] [Abstract][Full Text] [Related]
19. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
20. Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Starlander G; Yin H; Edquist P; Melhus Å
APMIS; 2014 Jan; 122(1):59-67. PubMed ID: 23755901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]